Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study - Wikidata - wikimedia - TriplyDB

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

http://www.wikidata.org/entity/Q28345604

about

Preventive pharmacologic treatments for episodic migraine in adults Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies The Migraine-Stroke Connection Migraine in the era of precision medicine Evidence-Based Treatments for Adults with Migraine EFNS guideline on the drug treatment of migraine - report of an EFNS task force The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers Italian guidelines for primary headaches: 2012 revised version Intraneuronal angiotensinergic system in rat and human dorsal root ganglia.Migraine and the risk for stroke and cardiovascular disease.Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients Prophylaxis of migraine headache Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.[Influence of treatments for migraine on quality of life: literature integrative review].Placebo response in the prophylaxis of migraine: a meta-analysis.Enalapril improves endothelial function in patients with migraine: A randomized, double-blind, placebo-controlled trial.New developments in migraine prophylaxis.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.Renin angiotensin system: A novel target for migraine prophylaxis.'Old drugs for new applications': can orthopedic research benefit from this strategy?General principles of migraine management: the changing role of prevention.Future pharmacologic targets for acute and preventive treatments of migraine.Evidence-based medicine in migraine prevention.Patient outcome in migraine prophylaxis: the role of psychopharmacological agents The acute and preventative treatment of episodic migraine.Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects.Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome Preventive Migraine Treatment.New drugs for migraine Migraine in the elderly: a review.Current trends in migraine prophylaxis.Preventive treatment in migraine and the new US guidelines Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications.A pharmacogenomic evaluation of migraine therapy.Polymorphisms in the renin-angiotensin system and migraine in women ACE D/I polymorphism, migraine, and cardiovascular disease in women Current migraine management - patient acceptability and future approaches.The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia.

P2860

Q24630992-CBA81471-4C5B-417D-8BC5-87D8C3CBBE8F Q24633523-7A79F133-AE37-41C6-9F06-2870D6618646 Q24658205-7829183A-6383-458F-BD94-295AC281AB6A Q26747260-126D25B9-8635-484C-BD81-10D8E57D5AA2 Q26748947-9E60FB83-F24F-47AF-8C0A-0441B1C07255 Q26769968-5C1CE589-AA73-498C-9567-8A04897F213E Q28219436-A2D6797D-BFA8-4E8E-9637-7D40EE844967 Q28354157-AFCE690D-6389-44FA-AC47-9AB6DB840D0B Q30466790-643E3A32-B700-4965-9A94-A95F51243BAD Q30496299-6DA6C42E-2F41-4BEE-B979-545E8D1DCBB3 Q30838502-8D40A90F-9EF5-474F-9479-4153568D83BA Q33325778-E19B9BCE-617E-4DD3-AE4D-D015CA0F8EAA Q33794672-F6FD8847-DF72-46E0-A187-8E8F913010D7 Q34093677-E82343C3-82C8-4B3F-978F-4E70E4A03EAE Q34387249-749D2BAD-A24D-4068-A0FB-2E10E156E1CE Q34621702-BC23054B-909B-4502-A614-1DFDF4526546 Q34714052-96DDD7C0-0D53-4C56-8859-80BD0041F8E9 Q35095175-F7DAE38C-F569-4CB6-824C-AF66E7FC0C3A Q35690766-1EE16726-3F59-4C14-80E6-FDB0B6EE7369 Q35890377-02AAC160-9965-4AF2-95B1-86D36B87614B Q36056952-06276048-8C4E-41C6-AF27-40C5F7F06F99 Q36099512-93CA856A-0C37-4CEB-BD0E-EEAE853A6DF7 Q36106970-BAA5CE35-BB23-404A-9C60-5CBD3785408C Q36153368-2FBD1886-97AD-4D5F-B119-FBEB8B11020C Q36160565-8CF62DF3-73FD-4575-BB21-07D9FFC96EF9 Q36239483-99377843-1D1E-4CA6-B282-7C4C65DF0B7F Q36260205-B0CD8AC0-1B6F-49E3-B305-1FAEB74FFA52 Q36261171-BAC14C49-87C3-409D-9043-27D45DAA1AF1 Q36267944-090D8A2D-24B0-4382-A354-79482F7F75EB Q36332611-3A40CE7D-8D08-44FA-859E-D80574A118E2 Q36719748-DF28B097-B1A8-4CAE-9FA7-CDCCC169F93B Q36787468-7311D52E-439A-4FDE-9D9C-23A5872C7867 Q36873484-5797A6CC-4818-4469-9384-F010216B2926 Q36895952-96AAA2E4-2A91-467F-8906-C9B34AC2457D Q36909258-7D6DC760-E872-45F4-A996-B251223C8E34 Q37102338-D2889EC2-6C88-4F81-AD4A-3351DF17960C Q37102490-126DBC43-1A71-4A8B-A9BA-DCAFB975A9AD Q37106936-FD0DBEE1-B76A-4B25-9DFF-7A38597C50F4 Q37176674-85D6CCE1-4D98-4053-AC34-388858177F80 Q37307404-196600EF-F21F-4BD3-B50D-16CDAD7C62C2

P2860

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

http://www.wikidata.org/entity/Q28345604

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Prophylactic treatment of migr ...... bo controlled, crossover study

@ast

Prophylactic treatment of migr ...... bo controlled, crossover study

@en

Prophylactic treatment of migr ...... bo controlled, crossover study

@nl

type

label

Prophylactic treatment of migr ...... bo controlled, crossover study

@ast

Prophylactic treatment of migr ...... bo controlled, crossover study

@en

Prophylactic treatment of migr ...... bo controlled, crossover study

@nl

prefLabel

Prophylactic treatment of migr ...... bo controlled, crossover study

@ast

Prophylactic treatment of migr ...... bo controlled, crossover study

@en

Prophylactic treatment of migr ...... bo controlled, crossover study

@nl

P1433

Q28345604-E7C7AA30-2B9D-43F8-A638-C0BD69232C68

P1476

Q28345604-E468872A-53AB-4130-88C6-9C91031322A4

P2093

Q28345604-2F6C5938-0395-4FE7-863D-1B03D888B1E6

Q28345604-3AC321AF-05FC-4C77-8B48-CEEDAA234FC7

P2860

Q28345604-4C567A93-18BC-4646-A413-DF06DDA5CC05

Q28345604-91BEAED6-6590-4285-B7B7-ACC03BDC204D

Q28345604-A90B8BE9-942F-435F-A024-5F5E5C7CB780

Q28345604-BE0C3607-BB61-4825-87F4-473563C6ED96

Q28345604-DC418AD1-4D49-4845-8618-BD32ABC5EB2F

Q28345604-F63E5318-79A4-43F9-B329-49592E1CAA57

P304

Q28345604-718021A9-43F6-48BA-9516-138493569DC4

P31

Q28345604-5E2DBE18-8FE4-4F00-89C9-05CAF1930B85

P3181

Q28345604-3626B0EC-BAA8-4D09-9300-C9A71097FBE7

P356

Q28345604-55DB0701-1DBD-4C0A-937F-66FE5C09ADAA

P407

Q28345604-B6C8D9A0-03E6-4883-88F4-3E7B779EC686

P433

Q28345604-A611B595-089A-4010-9BD3-471226DBC600

P478

Q28345604-50588E64-AE8D-47A8-89B1-ECBAF693B537

P50

Q28345604-1F2002B7-2DB1-44EE-BBD2-F821609F1A98

Q28345604-520ECE6C-B7D8-44C0-8899-4DA7B882C1EA

Q28345604-5C5F43DD-CE4A-4588-B79F-F824F4EBD608

P577

Q28345604-7EBEA9B2-A95C-49F6-B40D-F3C3E041AA6E

P5875

Q28345604-9C93C375-FDEE-4C2E-8CFC-15E31CF871A4

P698

Q28345604-BEE8369E-0D8B-4BBD-BDC0-34C441B679F8

P921

Q28345604-10FC731A-1B02-4E2B-88F8-6628BCC6D7C7

Q28345604-FE434B52-EB5C-4D03-A164-09F7B1FF82C6

P932

Q28345604-143836E3-553E-4C93-9171-A99338FA02B0

P3181

P356

BMJ.322.7277.19

P1433

P1476

Prophylactic treatment of migr ...... bo controlled, crossover study

@en

P2093

G Helde

http://www.w3.org/2001/XMLSchema#string

T Sand

http://www.w3.org/2001/XMLSchema#string

P2860

Propranolol in the management of recurrent migraine: a meta-analytic review.

The broad substrate specificity of human angiotensin I converting enzyme.

Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.

Introduction to sample size determination and power analysis for clinical trials.

Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study.

Malignant primary hypertension in pregnancy treated with lisinopril.

P304

19-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1166703

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJ.322.7277.19

http://www.w3.org/2001/XMLSchema#string

P407

P433

7277

http://www.w3.org/2001/XMLSchema#string

P478

322

http://www.w3.org/2001/XMLSchema#string

P50

Lars Jacob Stovner

Harald Schrader

P577

2001-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271378561

http://www.w3.org/2001/XMLSchema#string

P698

11141144

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

26600

http://www.w3.org/2001/XMLSchema#string